First-line maintenance treatment with the PARP inhibitor niraparib yielded a clinically meaningful and statistically significant improvement in progression-free survival vs placebo in Chinese patients with platinum-responsive advanced ovarian cancer, regardless of biomarker status, according to data from the phase 3 PRIME trial.
Emerging technology helps ensure best practices while reducing costs of care.
Family history assessment, genetic screening are key to prevention.
Risk assessment, lifestyle counseling, adverse effects, and medication management.
A teenager’s day-to-day behavior can vary greatly. Here are some tips for understanding and navigating this challenging time.
Clinical pearls for assessment and management of the pregnant patient with a uterovaginal anomaly.
In honor of World Health Day on April 7, our President and CEO, Mike Hennessy Jr, reflects on the founding of the World Health Organization in his monthly publisher's note.
Today is Physician Family Day, the perfect time to reflect and address any potential burnout symptoms and spend quality time re-engaging with your loved ones.
Risk assessment and management of brain arteriovenous malformations in pregnancy.
New trial results showed statistically significant improvements in overall survival and progression-free survival.
Cancer programs seek to remove barriers to screenings.
Kate White, MD, MPH, and Harold Bays, MD, discuss their hopes for the future of contraception options, affordability, and clinical trials evaluating their efficacy.
Survey examines yearly evolution of patient, doctor feelings on access to care.
Postpartum psychosis is experienced by 1 to 2 women every 1000 deliveries.
Understanding the technology behind a newer uterus-sparing option for the management of uterine fibroids.
Experts discuss management of women’s health including chronic pelvic pain resulting from endometriosis and heavy menstrual bleeding from uterine fibroids. They also discuss ways to help improve patient-provider communications and overcome the normalization associated with non-malignant gynecological conditions.
Oral contraceptive pills are a popular choice for many; providers should understand the options to guide patients effectively.
In this month's Practice Matters column, James D. Keller, MD, MHSA; and Brian K. Iriye, MD, explore the world of value-based care and how it can benefit your practice.
Treatment programs that often use neoadjuvant chemotherapy as a strategy may help prolong survival in patients with advanced ovarian cancer compared with those that infrequently used the tactic, which may reassure patients and providers.
Three esteemed surgeons discuss technology, weighing the pros and cons of existing and newly developed platforms.
Experts discuss the trajectory of CMV awareness and vaccine development efforts.
Here’s why we should be paying special attention to women’s depression treatment.
Interventions before and after birth can reduce the rising maternal mortality ratio.
Recommendations for maternity care professionals based on MiPATH.
From 1976 to 2018, data show the prevalence of obesity in the United States increased from 6.2% to 32.7%.
Halley Crissman, MD, MPH, shares her insight on the ways in which hospital systems reinforce cisnormativity and focal points to address for a more welcoming environment.
When considering the “health” of a medical practice, much of the focus is on financial indicators: missing collections at the time of service, recurring denials, poor claims management and aging patient balances. However, another area needs attention but is often overlooked: patient satisfaction.
The protocol presented here provides an algorithm for the initial evaluation of anemia in pregnancy, with treatment algorithms for the most common causes in pregnancy.
The American Medical Association is urging the FDA to approve OTC access to oral contraceptives.
Correct terms and education can help normalize the conversation for patients.